Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
-
Maris-Tech Expands European Reach with New Distribution Agreement in Poland
-
Repeat: EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025
-
Form 8.3 - [TRAKM8 HOLDINGS PLC - Opening Disclosure - 01 05 2025] - (CGAML)
-
Form 8.3 - [GLOBALDATA PLC - 01 05 2025] - (CGWL)
-
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
-
Nic Pouches Unveils New Loyalty Points Rewards System for All Customers
-
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
-
TurnOnGreen, Inc. Reports Strong Electric Vehicle Charging Network Growth in 2024
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
LGI Homes Expands Presence in Polk County with Launch of Peach Crossings in Winter Haven, Florida
-
Abercrombie & Fitch Co. to Report First Quarter 2025 Results on May 28, 2025
-
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
-
Dave & Buster’s Announces Board of Directors Transitions
-
iBio Reports Fiscal Third Quarter 2025 Financial Results
-
ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians
-
Star Group, L.P. to Host Fiscal 2025 Second Quarter Webcast and Conference Call May 8, 2025
-
Vislink Reports Fourth Quarter and Full Year 2024 Financial and Operational Results
-
ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025
-
Advanced Flower Capital Renews Senior Secured Revolving Credit Facility with Lead Commitment from FDIC-Insured Bank
-
CareCloud Announces Preferred Stock Dividend Payments
-
Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
-
Abercrombie & Fitch Co. to Report First Quarter 2025 Results on May 28, 2025
-
Harvia Plc: Disclosure under chapter 9, section 10 of the securities market act
-
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
-
Lerøy Seafood Group ASA: Notice of General Shareholders' Meeting
-
CHAR Tech and the BMI Group Forge Strategic Partnership to Accelerate Renewable Energy Projects and Announce $2M Private Placement
-
ALK enters into neffy® co-promotion agreement in the USA
-
IREN to Release Q3 FY25 Results on May 14, 2025
-
SUTNTIB AB Tewox publishes its NAV for April 2025
-
SCROOGE Casino Launches Revolutionary VIP Rakeback Program Amid Social Impact Expansion
-
IES Holdings Reports Fiscal 2025 Second Quarter Results
-
Invesco Ltd: Form 8.3 - QUALCOMM Inc; Public dealing disclosure
-
Moonacy Protocol adds support for Cardano
-
HODL 2025: Blockchain’s Brightest Minds. All in Dubai
-
Melco Announces Earnings Release Date
-
Invesco Ltd: Form 8.3 - PRS REIT Plc; Public dealing disclosure
-
Bitget Wallet Partners With Paydify to Expand Global Crypto Acceptance
-
Willis Lease Finance Corporation Announces Quarterly Dividend
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
SunPower (aka Complete Solaria, Inc.) Receives Notice of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
-
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
-
Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
-
Net Asset Value(s)
-
Studio City Announces Earnings Release Date
-
Vaisala Corporation: Managers’ Transactions – Hänninen, Samuli
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Asante Provides Financial and Operating Results for the Year Ended January 31, 2025
-
Impactive Capital Issues Letter to WEX Inc. Shareholders Announcing Its Intention to Vote Against Three Directors at 2025 Annual Meeting
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
